NCT07118930 - Study of Sivelestat Sodium in OPCABG | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Coronary Heart DiseaseCoronary Artery DiseaseCoronary Arterial Disease (CAD)

Interventions

DRUG

Sivelestat Sodium injection 2 h after OPCABG for 72 h

DRUG

Saline (0.9% NaCl)

Saline (0.9% NaCl) instead of Sivelestat

Trial Locations (1)

RECRUITING

Affiliated Hospital of Nantong University, Nantong

All Listed Sponsors

lead

Affiliated Hospital of Nantong University

OTHER